We are live on ! Find out more
Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $209B
1-Year Est. Return 39.39%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+39.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$209B
AUM Growth
-$13.9B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,488
New
Increased
Reduced
Closed

Top Buys

1 +$1.74B
2 +$1.16B
3 +$501M
4
PLTR icon
Palantir
PLTR
+$451M
5
DASH icon
DoorDash
DASH
+$411M

Top Sells

1 +$1.22B
2 +$866M
3 +$690M
4
DAY
Dayforce
DAY
+$576M
5
WDAY icon
Workday
WDAY
+$531M

Sector Composition

1 Technology 32.5%
2 Healthcare 20.49%
3 Industrials 11.17%
4 Consumer Discretionary 9.27%
5 Communication Services 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWONA icon
326
Liberty Media Series A
FWONA
$20.5B
$78.6M 0.04%
1,006,144
+10,603
WAB icon
327
Wabtec
WAB
$43.5B
$78.3M 0.04%
313,398
+1,025
CIGI icon
328
Colliers International
CIGI
$5.05B
$78.1M 0.04%
725,961
+76,588
TERN
329
DELISTED
Terns Pharmaceuticals
TERN
$77.5M 0.04%
1,470,057
-1,909,512
STN icon
330
Stantec
STN
$8.14B
$77.3M 0.04%
903,925
-2,547
RLMD icon
331
Relmada Therapeutics
RLMD
$669M
$76.9M 0.04%
11,063,862
+3,793,862
ZS icon
332
Zscaler
ZS
$20.2B
$76M 0.04%
541,671
+173,268
MIR icon
333
Mirion Technologies
MIR
$3.87B
$75.2M 0.04%
4,043,089
-553,860
MLI icon
334
Mueller Industries
MLI
$14.6B
$74.9M 0.04%
676,052
+70,433
LFUS icon
335
Littelfuse
LFUS
$11.1B
$74.2M 0.04%
218,571
-468
BDX icon
336
Becton Dickinson
BDX
$40.7B
$73.5M 0.04%
467,396
+46,157
IBM icon
337
IBM
IBM
$256B
$73.4M 0.04%
302,610
-9,634
GLBE icon
338
Global E Online
GLBE
$5.5B
$72.8M 0.03%
2,360,866
+91,384
J icon
339
Jacobs Solutions
J
$14.4B
$72.5M 0.03%
569,689
+101,137
NAMS icon
340
NewAmsterdam Pharma
NAMS
$3.43B
$72.3M 0.03%
2,258,984
-82,739
TOL icon
341
Toll Brothers
TOL
$13B
$72.2M 0.03%
528,903
+62,168
MNPR icon
342
Monopar Therapeutics
MNPR
$398M
$72.1M 0.03%
1,317,410
HQY icon
343
HealthEquity
HQY
$7.5B
$71.1M 0.03%
850,411
+30,178
SRAD icon
344
Sportradar
SRAD
$4.95B
$69.6M 0.03%
4,157,470
+1,306
AMLX icon
345
Amylyx Pharmaceuticals
AMLX
$1.5B
$69.3M 0.03%
4,986,073
+520,201
ETR icon
346
Entergy
ETR
$50.6B
$69.1M 0.03%
614,906
+87,561
KRYS icon
347
Krystal Biotech
KRYS
$9.21B
$68.9M 0.03%
266,659
+47,219
AME icon
348
Ametek
AME
$50.8B
$68.8M 0.03%
321,113
-78,040
INSM icon
349
Insmed
INSM
$19.9B
$68.6M 0.03%
419,304
-381,251
LHX icon
350
L3Harris
LHX
$56.4B
$68.5M 0.03%
198,606
-31,565